Not registered yet? Get a free account.
Sign UpYou're about to leave our website and go to an external link. Are you sure?
The company manufactures chemicals such as natural gums, spirits, industrial gases, sugar and nutraceuticals.
Solara Active Pharma Sciences Limited, is an unlisted public company incorporated on 23 February, 2017. It is classified as a public limited company and is located in Thane, Maharashtra. It's authorized share capital is INR 120.00 cr and the total paid-up capital is INR 40.20 cr.
Read more
This action will use 1 of your credits. Are you sure you want to go ahead?
** All rupee values in INR crores. Based on March 2023 numbers.
* GST not included
** Reports & MCA filings will be based on the latest available financials.
State | Type | Address |
---|
Read more
Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | |
---|---|---|---|---|---|
Sales | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Operating profit | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Net profit | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Gross margin | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Operating margin | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Net margin | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Networth | |||||
Borrowings | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Assets | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Debt to equity | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Current ratio | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
ROE | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Days payable | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
WC days | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | |
---|---|---|---|---|---|
Equity Capital | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Reserves | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Borrowings + | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Long term borrowings | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Short term borrowings | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Trade payables + | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Days payable | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Other liabilities + | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Other non-current liabilities | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Other current liabilities | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Total liabilities | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Fixed Assets + | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Tangible assets | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
CWIP | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Intangible assets | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
LT loans and advances | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Other non-current assets | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Current assets + | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Inventories | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Trade receivables | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Cash and cash equivalents | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
ST loans and advances | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Other current assets | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Total assets | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | |
---|---|---|---|---|---|
Sales + | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Sales growth % | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Expenses + | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Cost of goods | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Employee cost | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Other costs | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Operating profit + | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Operating margin % | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Other income | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Interest | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Depreciation | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Exceptional items | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Profit before tax | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Tax | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Profit - disc. ops | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Net profit | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Net margin % | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | |
---|---|---|---|---|---|
Solvency + | |||||
Total Debt/Equity | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Net Debt/Equity | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Total Debt/Assets | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Total Assets/Equity | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Liquidity + | |||||
Current Ratio | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Quick Ratio | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Interest Coverage | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Performance | |||||
Gross Margin | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Operating Margin | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Net Margin | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Return + | |||||
Return on Equity | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Pre-tax ROCE | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Return on Assets | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Pre-tax ROIC | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Efficiency + | |||||
Days Payable | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Days Inventory | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Days Receivable | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Fixed Asset Turnover | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Total Asset Turnover | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Working Capital | |||||
Cash Conversion Cycle | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Working Capital Days | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Axis Trustee Services Limited
No. of Loans: 1
Total Amount : 1,264.4 cr
ICICI Bank Limited
No. of Loans: 1
Total Amount : 170.0 cr
Kotak Mahindra Bank Limited
No. of Loans: 1
Total Amount : 150.0 cr
Yes Bank Limited
No. of Loans: 2
Total Amount : 140.0 cr
Designation | Name | DIN/PAN | Tenure |
---|---|---|---|
Director | Arun Kumar Pillai
Shareholder
|
00084845 | 3 years |
Director | Ramakrishnan Rajagopal
Shareholder
|
00161542 | 7 years |
Director | Kartheek Chintalapati Raju | 02921819 | 1 years |
Director | Mohan Muthunarayanan | 03610282 | 1 years |
Director | Manish Gupta | 06805265 | 0 years |
Director | Kausalya Santhanam | 06999168 | 7 years |
Director | Rajendra Kumar Srivastava | 07500741 | 1 years |
CEO | Poorvank Purohit | <HIDDEN> | 2 years |
Director | Poorvank Purohit | 10158900 | 1 years |
Director | Rajiv Vijay Nabar | 10383397 | 1 years |
CS | Suddapalli Muralikrishna
Shareholder
|
<HIDDEN> | 7 years |
Kmp | Arun Kumar Baskaran | <HIDDEN> | 1 years |
Name | Status | Paid up Capital | Common Directors | Address |
---|---|---|---|---|
SKANRAY HEALTHCARE PRIVATE LIMITED |
Amalgamated
|
7.1 Cr | 1 | Karnataka |
SEQUENT SCIENTIFIC LIMITED |
Amalgamated
|
4.3 Cr | 1 | Maharashtra |
STRIDES PHARMA SCIENCE LIMITED |
Active
|
92.0 Cr | 2 | Maharashtra |
FRAXIS LIFE SCIENCES LIMITED |
Amalgamated
|
2.0 Cr | 1 | Maharashtra |
ARCOLAB (INDIA) P.LTD. |
Amalgamated
|
1.0 L | 1 | Karnataka |
ONESOURCE SPECIALTY PHARMA LIMITED |
Active
|
4.2 Cr | 1 | Karnataka |
GRANDIX PHARMACEUTICALS LIMITED |
Amalgamated
|
46.4 L | 1 | Tamil Nadu |
CHAYADEEP VENTURES LLP |
Active
|
1.0 L | 1 | Karnataka |
AGNUS CAPITAL LLP |
Active
|
1.0 L | 1 | Karnataka |
QUALICHEM REMEDIES LLP |
Active
|
1.0 L | 1 | Karnataka |
QUADGEN WIRELESS SOLUTIONS PRIVATE LIMITED |
Active
|
156.2 Cr | 1 | Karnataka |
MURUDESHWAR DECOR PRIVATE LIMITED |
Active
|
1.4 Cr | 1 | Karnataka |
MULTIVISION SOFTWARE SOLUTIONS PRIVATE LIMITED |
Active
|
5.0 L | 1 | Karnataka |
VVAR GAMING ENTERPRISE LLP |
Under Process Of Strike Off
|
1.0 L | 1 | Telangana |
CHINTALAPATI CAPITAL HOLDINGS LLP |
Active
|
50.0 Cr | 1 | Telangana |
TELLAPUR PROPERTIES LLP |
Active
|
1.1 Cr | 1 | Telangana |
DRAGON WORKS PRODUCTION LLP |
Active
|
1.0 L | 1 | Telangana |
MONITRA ENVIRO PRIVATE LIMITED |
Active
|
2.0 L | 1 | Pondicherry |
JAGSON PAL PHARMACEUTICALS LIMITED. |
Active
|
13.2 Cr | 1 | Delhi |
DESH SEVA SAMITI |
Active
|
0.0 | 1 | Maharashtra |
SEQUENT SCIENTIFIC LIMITED |
Active
|
49.9 Cr | 1 | Maharashtra |
GROW DIGI INDIA LIMITED |
Active
|
5.0 L | 1 | Delhi |
LATTICED ADVISORS LLP |
Active
|
3.0 L | 1 | Telangana |
HAPPIEST MINDS TECHNOLOGIES LIMITED |
Active
|
30.5 Cr | 1 | Karnataka |
TAC INFOSEC LIMITED |
Active
|
10.5 Cr | 1 | Punjab |
SHASUN PHARMACEUTICALS LIMITED |
Amalgamated
|
13.5 Cr | 1 | Tamil Nadu |
STRIDES CHEMICALS PRIVATE LIMITED |
Amalgamated
|
79.7 Cr | 1 | Maharashtra |
Name | State / Country | Incorporation Year | Paidup Capital |
---|---|---|---|
CHEMSYNTH LABORATORIES PRIVATE LIMITED | Telangana | 2009 | ₹ 6.9 Cr |
SEQUENT PENEMS PRIVATE LIMITED | Karnataka | 2010 | ₹ 4.5 Cr |
Shasun Inc., USA | United States | - | - |
Solara Active Pharma Sciences LTDA* | Brazil | - | - |
Shasun USA Inc | United States | - | - |
Solara Active Pharma Sciences LTDA | Brazil | - | - |
The incorporation date of SOLARA ACTIVE PHARMA SCIENCES LIMITED is 23 February, 2017
The authorized share capital of SOLARA ACTIVE PHARMA SCIENCES LIMITED is INR ₹ 120.0 Cr.
The paid-up capital of SOLARA ACTIVE PHARMA SCIENCES LIMITED is INR ₹ 40.2 Cr.
The registered address of SOLARA ACTIVE PHARMA SCIENCES LIMITED is 201, Devavrata, Sector 17, Vashi, NA Navi Mumbai Thane Maharashtra - 400703
The CIN number of SOLARA ACTIVE PHARMA SCIENCES LIMITED is L24230MH2017PLC291636.